Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Keratosis, Actinic 22 Brain Neoplasms 10 Glioma 7 Glioblastoma 7 Carcinoma, Basal Cell 4 Precancerous Conditions 2 Mycosis Fungoides 2 Mouth Neoplasms 2 Meningioma 2 Lymphoma, T-Cell, Cutaneous 2 Gliosarcoma 2 Basal Cell Nevus Syndrome 2 Urinary Bladder Neoplasms 1 Squamous Intraepithelial Lesions 1 Skull Base Neoplasms 1 Skin Neoplasms 1 Sezary Syndrome 1 Pituitary Neoplasms 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Nonmelanoma Skin Cancers 1 Neurofibromatoses 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Lymphoma 1 Leukoplakia 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1

Interventions

Gemcitabine 79 Cisplatin 56 pembrolizumab 32 Paclitaxel 28 Carboplatin 24 Docetaxel 19 Radiotherapy 17 Mitomycin 16 Doxorubicin 15 atezolizumab 14 BCG Vaccine 14 Nivolumab 13 Cystectomy 13 Filgrastim 11 vinflunine 10 Methotrexate 10 Vinblastine 9 Fluorouracil 9 5-aminolevulinic acid hexyl ester 9 Sunitinib 7 Early Intervention, Educational 7 durvalumab 6 avelumab 6 Taxes 6 Methods 6 Cystoscopy 6 Albumin-Bound Paclitaxel 6 enfortumab vedotin 5 Trastuzumab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Urinary Bladder Neoplasms × Aminolevulinic Acid × Clear all

NCT02101931 2016-03-31

ALA

Princess Al-Johara Al-Ibrahim Cancer Research Center

Phase 3 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡